EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan

Seiki Hasegawa iD, Yasushi Shintani iD, Teruhisa Takuwa, Keisuke Aoe, Katsuya Kato, Nobukazu Fujimoto iD, Yasuhiro Hida, Masahiro Morise, Yasumitsu Moriya, Takao Morohoshi, Hidemi Suzuki, Masayuki Chida und 6 weitere

Cancer Science · 2024-02 · 115 (2) · 507-528

DOI: 10.1111/cas.16021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 04.12.2023. Verfasst von Seiki Hasegawa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Hyogo Medical University, Hyogo, Japan. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Mesothelioma, Pleural Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Japanese Joint Committee for Lung Cancer Registry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the scarcity of large‐sized prospective databases, the Japanese Joint Committee for Lung Cancer Registry conducted a nationwide prospective registry for newly diagnosed and untreated pleural mesothelioma. All new cases diagnosed pathologically as any subtype of pleural mesothelioma in Japan during the period between April 1, 2017, to March 31, 2019, were included before treatment. Data on survival were collected in April 2021. The eligible 346 patients (285 men [82.3%]; 61 women [17.7%]; median age, 71.0 years [range, 44–88]) were included for analysis. Among these patients, 138 (39.9%) underwent surgery, 164 (47.4%) underwent non‐surgical therapy, and the remaining 44 (12.7%) underwent best supportive care. The median overall survival for all 346 patients was 19.0 months. Survival rates at 1, 2, and 3 years for all patients were, 62.8%, 42.3%, and 26.5%, respectively. Median overall survival was significantly different among patients undergoing surgery, non‐surgical treatment, and best supportive care (32.2 months vs. 14.0 months vs. 3.8 months, p < 0.001). The median overall survival of patients undergoing pleurectomy/decortication and extrapleural pneumonectomy was 41.8 months and 25.0 months, respectively. Macroscopic complete resection resulted in longer overall survival than R2 resection and partial pleurectomy/exploratory thoracotomy (41.8 months vs. 32.2 months vs. 16.8 months, p < 0.001). Tumor shape, maximum tumor thickness, and sum of three level thickness were significant prognostic factors. The data in the prospective database would serve as a valuable reference for clinical practice and further studies for pleural mesothelioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesothelioma, MalignantMesotheliomaPleural NeoplasmsLung NeoplasmsMaleHumansFemaleAgedJapanTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

chemotherapydatabasepleural mesotheliomastaging systemsurgery

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Hyogo Medical University, Hyogo, Japan.
  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Department of Medical Oncology, National Hospital Organization Yamaguchi-Ube Medical Center, Yamaguchi, Japan.
  • Department of Diagnostic Radiology 2, Kawasaki Medical School, Okayama, Japan.
  • Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan.
  • Department of Cardiovascular and Thoracic Surgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.

ORCID-Profile: Seiki Hasegawa, Yasushi Shintani, Nobukazu Fujimoto

Förderung

  • The Japanese Joint Committee for Lung Cancer Registry

Zitieren

APA

Hasegawa, S., Shintani, Y., Takuwa, T., Aoe, K., Kato, K., Fujimoto, N., Hida, Y., Morise, M., Moriya, Y., Morohoshi, T., Suzuki, H., Chida, M., Endo, S., Kadokura, M., Okumura, M., Hattori, S., Date, H., & Yoshino, I. (2024). Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan. Cancer Science, 115(2), 507-528. https://doi.org/10.1111/cas.16021

Vancouver

Hasegawa S, Shintani Y, Takuwa T, Aoe K, Kato K, Fujimoto N, et al. Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan. Cancer Science. 2024;115(2):507-528. doi:10.1111/cas.16021

BibTeX
@article{Hasegawa2024,
  author = {Hasegawa, Seiki and Shintani, Yasushi and Takuwa, Teruhisa and Aoe, Keisuke and Kato, Katsuya and Fujimoto, Nobukazu and Hida, Yasuhiro and Morise, Masahiro and Moriya, Yasumitsu and Morohoshi, Takao and Suzuki, Hidemi and Chida, Masayuki and Endo, Shunsuke and Kadokura, Mitsutaka and Okumura, Meinoshin and Hattori, Satoshi and Date, Hiroshi and Yoshino, Ichiro},
  title = {Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {2},
  pages = {507--528},
  doi = {10.1111/cas.16021}
}
Kostenlos starten →